Opus Capital Group, LLC
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1330325
CINCINNATI, OH
Position in SLS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,691,515
+$4,226,024 QoQ
Shares Held
385,604
+11.3% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
9.88%
of 13F equity value
Holder Rank
#22
of 192 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Opus Capital Group, LLC holds $5,800,586 across 3 Biotechnology names. SLS ranks #1 (98.1% of the industry book) .
All Filings in SLS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,691,515 | 385,604 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,465,491 | 346,452 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,195,467 | 317,100 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $402,500 | 250,000 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $525,600 | 240,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $258,660 | 239,500 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $248,040 | 238,500 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $282,625 | 226,100 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $262,990 | 221,000 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $202,606 | 200,600 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $143,100 | 135,000 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $56,580 | 34,500 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $48,670 | 31,000 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $35,750 | 25,000 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $46,425 | 19,672 | Shares | Sole | 2023-01-18 | |
| No filing history on record for this holder in this stock. | ||||||